GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (SHSE:603127) » Definitions » EPS without NRI

Joinn Laboratories (China) Co (SHSE:603127) EPS without NRI : ¥0.21 (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Joinn Laboratories (China) Co EPS without NRI?

Joinn Laboratories (China) Co's earnings per share without non-recurring items for the three months ended in Mar. 2024 was ¥0.06. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.21.

During the past 12 months, Joinn Laboratories (China) Co's average earnings per share (NRI) Growth Rate was -80.10% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -1.20% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 37.40% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 31.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Joinn Laboratories (China) Co's EPS without NRI or its related term are showing as below:

SHSE:603127' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -1.2   Med: 30.3   Max: 75.7
Current: -1.2

During the past 12 years, Joinn Laboratories (China) Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 75.70% per year. The lowest was -1.20% per year. And the median was 30.30% per year.

SHSE:603127's 3-Year EPS without NRI Growth Rate is ranked worse than
51.48% of 169 companies
in the Medical Diagnostics & Research industry
Industry Median: -0.8 vs SHSE:603127: -1.20

Joinn Laboratories (China) Co's EPS (Diluted) for the three months ended in Mar. 2024 was ¥-0.36. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.09.

Joinn Laboratories (China) Co's EPS (Basic) for the three months ended in Mar. 2024 was ¥-0.36. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.09.


Joinn Laboratories (China) Co EPS without NRI Historical Data

The historical data trend for Joinn Laboratories (China) Co's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co EPS without NRI Chart

Joinn Laboratories (China) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.47 0.73 1.36 0.45

Joinn Laboratories (China) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 -0.14 0.32 -0.03 0.06

Competitive Comparison of Joinn Laboratories (China) Co's EPS without NRI

For the Diagnostics & Research subindustry, Joinn Laboratories (China) Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Joinn Laboratories (China) Co's PE Ratio without NRI Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Joinn Laboratories (China) Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Joinn Laboratories (China) Co's PE Ratio without NRI falls into.



Joinn Laboratories (China) Co EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Joinn Laboratories (China) Co  (SHSE:603127) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Joinn Laboratories (China) Co EPS without NRI Related Terms

Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Joinn Laboratories (China) Co (SHSE:603127) Business Description

Traded in Other Exchanges
Address
A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.
Executives
Yao Da Lin Director
Sun Yun Xia Director
Zuo Cong Lin Director
Gao Da Peng Director
Li Ye Supervisors
Gu Xiao Lei Director
Feng Yu Xia Director
Gu Jing Liang senior management
Yu Ai Shui senior management
Yin Li Li Supervisors
Sun Hui Ye Supervisors
Gu Mei Fang Director

Joinn Laboratories (China) Co (SHSE:603127) Headlines

No Headlines